Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,867.54 -2,015.52 (-3.21%) CMC Crypto 200
1,261.28 -96.72 (-7.12%)
Fresenius SE & Co. KGaA (FSNUF)
| Previous close | 30.75 |
| Open | 30.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 30.00 - 30.00 |
| 52-week range | 25.77 - 32.43 |
| Volume | |
| Avg. volume | 715 |
| Market cap | 16.966B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 44.12 |
| EPS (TTM) | 0.68 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 0.99 (3.26%) |
| Ex-dividend date | 18 May 2023 |
| 1y target est | 8.64 |
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
Simply Wall St.Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
Key Insights Fresenius SE KGaA's significant retail investors ownership suggests that the key decisions are influenced...
- Simply Wall St.
Is Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Today we're going to take a look at the well-established Fresenius SE & Co. KGaA ( ETR:FRE ). The company's stock saw...
